T. Rowe Price Associates
AHCO icon

T. Rowe Price Associates’s AdaptHealth AHCO Stock Holding History

T. Rowe Price Associates’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
127,036
+25,338
+25% +$283K ﹤0.01% 2192
2026
Q1 		$1.21M Buy
101,698
+21,639
+27% +$221K ﹤0.01% 2059
2025
Q4 		$798K Sell
80,059
-7,866
-9% -$75.1K ﹤0.01% 2176
2025
Q3 		$787K Buy
87,925
+6,375
+8% +$59K ﹤0.01% 2166
2025
Q2 		$770K Buy
81,550
+3,254
+4% +$28.7K ﹤0.01% 2098
2025
Q1 		$849K Buy
78,296
+4,306
+6% +$43.3K ﹤0.01% 2039
2024
Q4 		$705K Buy
73,990
+10,451
+16% +$106K ﹤0.01% 2131
2024
Q3 		$714K Buy
63,539
+1,150
+2% +$12.2K ﹤0.01% 2108
2024
Q2 		$624K Buy
62,389
+4,515
+8% +$45.9K ﹤0.01% 2103
2024
Q1 		$667K Buy
57,874
+4,575
+9% +$38.9K ﹤0.01% 2088
2023
Q4 		$389K Buy
53,299
+5,464
+11% +$43.1K ﹤0.01% 2281
2023
Q3 		$436K Buy
47,835
+8,972
+23% +$108K ﹤0.01% 2175
2023
Q2 		$473K Buy
38,863
+1,211
+3% +$13.5K ﹤0.01% 2159
2023
Q1 		$469K Buy
37,652
+984
+3% +$18.1K ﹤0.01% 2133
2022
Q4 		$705K Sell
36,668
-2,589
-7% -$54.7K ﹤0.01% 1971
2022
Q3 		$738K Buy
39,257
+4,742
+14% +$97.5K ﹤0.01% 1923
2022
Q2 		$623K Buy
34,515
+7,977
+30% +$130K ﹤0.01% 2126
2022
Q1 		$425K Buy
26,538
+13,089
+97% +$235K ﹤0.01% 2409
2021
Q4 		$329K Sell
13,449
-10,738
-44% -$252K ﹤0.01% 2562
2021
Q3 		$563K Sell
24,187
-5,979
-20% -$145K ﹤0.01% 2327
2021
Q2 		$827K Buy
30,166
+5,101
+20% +$145K ﹤0.01% 2153
2021
Q1 		$921K Buy
25,065
+13,960
+126% +$493K ﹤0.01% 2097
2020
Q4 		$417K Buy
+11,105
New +$344K ﹤0.01% 2315

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates's AHCO Position: Q2 2026 in Review

T. Rowe Price Associates increased its AdaptHealth (AHCO) stake by 25% in Q2 2026, buying an estimated $283K and bringing the position to 127,036 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

T. Rowe Price Associates first reported a position in AHCO in Q4 2020 and has held it in 23 quarters since. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • T. Rowe Price Associates held 127,036 shares of AdaptHealth worth $1.32M as of Q2 2026.
  • T. Rowe Price Associates bought 25,338 AdaptHealth shares in Q2 2026, an estimated $283K.
  • AdaptHealth made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2192 holding.
  • T. Rowe Price Associates first reported a position in AdaptHealth in Q4 2020 and has held it in 23 quarters since.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.